NeuroPace, Inc. (NPCE)
13.95
+0.80
(+6.08%)
USD |
NASDAQ |
Apr 01, 12:21
NeuroPace EPS Diluted (Quarterly) : -0.0817 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sight Sciences, Inc. | -0.0784 |
| Standard BioTools, Inc. | 0.0501 |
| Ludwig Enterprises, Inc. | -0.0066 |
| QHSLab, Inc. | 0.0325 |
| Zomedica Corp. | -0.0046 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.729M |
| Revenue (Quarterly) | 26.59M |
| Total Expenses (Quarterly) | 29.32M |
| Enterprise Value | 452.50M |
| Gross Profit Margin (Quarterly) | 77.40% |
| Profit Margin (Quarterly) | -10.26% |
| Earnings Yield | -4.73% |
| Normalized Earnings Yield | -4.655 |